Back
Mirati Therapeutics Stock Price Chart
Sponsored
Your Chance To Invest In The Green Energy Revolution!
Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!
Buy
53
MRTX
Mirati Therapeutics
Last Price:
52.56
Seasonality Move:
-5.31%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
New Year, New Trades, Try A.I. Today
Learn to forecast trends with up to 87.4% proven accuracy -> Register Here- The current trend is relatively stagnant and MRTX is experiencing slight selling pressure.
Mirati Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.26 | Buy |
| 20-day SMA: | 47.24 | Buy |
| 50-day SMA: | 54.31 | Sell |
| 200-day SMA: | 64.16 | Sell |
| 8-day EMA: | 51.83 | Buy |
| 20-day EMA: | 49.6 | Buy |
| 50-day EMA: | 52.81 | Sell |
| 200-day EMA: | 70.42 | Sell |
Mirati Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1 | Buy |
| Relative Strength Index (14 RSI): | 56.35 | Buy |
| Chaikin Money Flow: | -15628 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.65 - 51.29) | Buy |
| Bollinger Bands (100): | (46.33 - 77.45) | Sell |
Mirati Therapeutics Technical Analysis
| Jan-23 | Jan-24 | Jan-25 | Jan-26 | Jan-27 | Jan-30 | Jan-31 | Feb-1 | Feb-2 | Feb-3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Mirati Therapeutics Stock
Is Mirati Therapeutics Stock a Buy?
- Mirati Therapeutics share price is 52.57 while MRTX 8-day simple moving average is 52.26, which is a Buy signal.
- The stock price of MRTX is 52.57 while Mirati Therapeutics 20-day SMA is 47.24, which makes it a Buy.
- Mirati Therapeutics 50-day simple moving average is 54.31 while MRTX share price is 52.57, making it a Sell technically.
- MRTX stock price is 52.57 and Mirati Therapeutics 200-day simple moving average is 64.16, creating a Sell signal.
MRTX Technical Analysis vs Fundamental Analysis
Buy
53
Mirati Therapeutics (MRTX)
is a Buy
Is Mirati Therapeutics a Buy or a Sell?
-
Mirati Therapeutics stock is rated a Buy
The current Mirati Therapeutics [MRTX] share price is $52.57. The Score for MRTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Mirati Therapeutics Stock Info
Market Cap:
3.03B
Price in USD:
52.57
Share Volume:
1.01M
Mirati Therapeutics 52-Week Range
52-Week High:
124.81
52-Week Low:
32.96
Buy
53
Mirati Therapeutics (MRTX)
is a Buy
Mirati Therapeutics Share Price Forecast
-
What is the Mirati Therapeutics stock price today?
The Mirati Therapeutics stock price is 52.57 USD today. -
Will MRTX stock go up or go down?
Mirati Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Mirati Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Mirati Therapeutics is not overvalued.
Is Mirati Therapeutics Stock a Buy?
- Mirati Therapeutics share price is 52.57 while MRTX 8-day exponential moving average is 51.83, which is a Buy signal.
- The stock price of MRTX is 52.57 while Mirati Therapeutics 20-day EMA is 49.60, which makes it a Buy.
- Mirati Therapeutics 50-day exponential moving average is 52.81 while MRTX share price is 52.57, making it a Sell technically.
- MRTX stock price is 52.57 and Mirati Therapeutics 200-day simple moving average is 70.42, creating a Sell signal.
Fundamental Analysis of Mirati Therapeutics
Is Mirati Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $2.53 per share.
Technical Analysis of Mirati Therapeutics
Should I short Mirati Therapeutics stock?
- MRTX Moving Average Covergence Divergence (MACD) indicator is 1, suggesting Mirati Therapeutics is a Buy
- Mirati Therapeutics Relative Strength Index (RSI) is 56.35, which suggest Mirati Therapeutics is overbought
- The Bollinger Bands (25) for Mirati Therapeutics is (42.65 - 51.29), which suggest Mirati Therapeutics is a Sell
- The Bollinger Bands (100) for Mirati Therapeutics is (46.33 - 77.45), which suggest Mirati Therapeutics is a Sell
* Mirati Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.